26452-96-0

Basic information

• Product Name: METHYL INDANE-1-CARBOXYLATE
• Synonyms: METHYL INDANE-1-CARBOXYLATE;Methyl 2,3-dihydro-1H-indene-1-carboxylate
• CAS NO: 26452-96-0
• Molecular Formula: C₁₁H₁₂O₂
• Molecular Weight: 176.21
• Mol File: 26452-96-0.mol
• Article Data: 21

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: METHYL INDANE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL INDANE-1-CARBOXYLATE(26452-96-0)
• EPA Substance Registry System: METHYL INDANE-1-CARBOXYLATE(26452-96-0)

Safety Data

• Hazardous Substances Data: 26452-96-0(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Synthesis, p. 880, 1979 DOI: 10.1055/s-1979-28857

Upstream product

• 71878-80-3 1-(methoxymethyl)-1H-benzotriazole 
• 83-33-0 inden-1-one 
• 292638-85-8 acrylic acid methyl ester 
• 307496-27-1 2-bromobenzylzinc(II) bromide 
• 55288-83-0 3-(indan-1-yl)propionic acid 
• 95-13-6 1-indene 
• 14209-41-7 3H-indene-1-carboxylic acid 
• 40685-04-9 1,2,3,4-tetrahydro-2-(hydroxymethylene)naphthalen-1-one 
• 67-56-1 methanol 
• 19156-10-6 indan-1-carbonyl chloride 
• 14381-42-1 Indan-1-carboxylic acid 
• 529-34-0 3,4-dihydronaphthalene-1(2H)-one 
• 56175-46-3 2-diazo-3,4-dihydronaphthalen-1(2H)-one 
• 7007-34-3 1-(3,4-dihydro-1-naphthalenyl)pyrrolidine 

Downstream Products

• 877-01-0 (R)-2,3-dihydro-1H-indene-1-carboxylic acid 
• 68000-22-6 (S)-2,3-dihydro-1H-indene-1-carboxylic acid 
• 1186102-40-8 1-(1-benzyl-2,3-dihydro-1H-inden-1-yl)-2-bromoethanone 
• 57625-82-8 methyl 1-benzylindane-1-carboxylate 
• 124015-63-0 C₁₉H₁₈O₃S 
• 176589-91-6 (1R)-N-((S)-1-hydroxymethylbenzyl)-1,6-dibenzylindan-1-carboxamide 
• 176503-92-7 (1S)-N-((S)-1-hydroxymethylbenzyl)-1,6-dibenzylindan-1-carboxamide 
• 176589-93-8 (R)-1,6-dibenzylindan-1-carboxylic acid 
• 176589-92-7 (S)-1,6-dibenzylindan-1-carboxylic acid 
• 176503-89-2 1,6-dibenzylindan-1-carboxylic acid 

Relevant articles and documents

-

-

CD73 INHIBITORS AND THERAPEUTIC USES THEREOF

This application discloses CD73 inhibitors of the general formula (I) and analogs thereof, pharmaceutical compositions containing these compounds, methods of preparing them, and use of these compounds as therapeutic agents for the treatment of diseases or conditions associated with CD73 activity, such as various cancers. Formula (I).

Alkoxycarbonylation of olefins with carbon dioxide by a reusable heterobimetallic ruthenium-cobalt catalytic system

The heterobimetallic ruthenium-cobalt catalytic system exhibited good catalytic performance and reusability in the reductive alkoxycarbonylation of olefins with carbon dioxide. Compared to the previous system only consisting of ruthenium catalyst, the binary catalyst system effectively reduced the usage of noble metal and ionic liquid additives. The respective contribution of ruthenium and cobalt catalysts in this multiple-step catalytic process was investigated by a series of condition-controlled experiments. The evolution of the ruthenium catalyst and the occurrence of alkene hydrogenation during the reaction was explained by theortical calculations.